Company Filing History:
2 out of 4 
2 out of 1,287 
1 out of 950 
Years Active: 2015-2020
Title: Shunpei Ishikawa: Innovator in Cancer Diagnosis and Treatment
Introduction
Shunpei Ishikawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of various cancers. With a total of 3 patents, his work focuses on innovative methods that utilize antibodies for cancer detection and therapy.
Latest Patents
One of his latest patents involves the diagnosis and treatment of cancer using anti-desmoglein-3 antibodies. This invention discloses methods that involve the detection of a DSG3 protein for diagnosing cancer. In lung cancer, the expression of DSG3 was found to be enhanced at very high frequency at both the gene and protein levels. The methods can be carried out using an antibody that recognizes a DSG3 protein. Additionally, pharmaceutical compositions, cell growth inhibitors, and anticancer agents containing a DSG3-binding antibody as an active ingredient are also disclosed. Another significant patent relates to the diagnosis and treatment of cancer using an anti-TM4SF20 antibody. This invention provides an antibody that binds to a TM4SF20 protein, along with a pharmaceutical composition that includes the antibody as an active ingredient.
Career Highlights
Shunpei Ishikawa has worked with notable organizations such as Forerunner Pharma Research Co., Ltd. and the University of Tokyo. His career is marked by a commitment to advancing cancer research and developing effective treatment methods.
Collaborations
Throughout his career, Ishikawa has collaborated with esteemed colleagues, including Hiroyuki Aburatani and Shigeto Kawai. These collaborations have further enriched his research and contributed to the development of innovative cancer therapies.
Conclusion
Shunpei Ishikawa's work in cancer diagnosis and treatment exemplifies the impact of innovative research in the medical field. His patents reflect a dedication to improving patient outcomes through advanced therapeutic methods.